References included in article:

Order of appearence	Full citation	SRCosmos Link
1	Mc-Lean M, Bisits A, Davies J, Woods R, Lowry P, Smith R, 1995. A placental clock controlling the length of human pregnancy. Nat Med, 1:460-463.
2	Hunter CAJ, Howard WF, 1961. Etiology of hypertension in toxemia of pregnancy. Am J Obstet Gynecol, 81:441-450.
3	Zhou Y, Damsky CH, Fisher SJ, 1997. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest, 99:2152-2164.
4	Khong TY, De-Wolf F, Robertson WB, Brosens I, 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infantsBr J Obstet Gynaecol, 93:1049-1059.
5	Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA, 1992. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol, 9:179-184.
6	Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR, 1996. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia, 39:1299-1305.
7	Seckl JR, Benediktsson R, Lindsay RS, Brown RW, 1995. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol, 55:447-455.
8	Redline RW, 2005. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol, 192:452-457.
9	Hauser R, Calafat AM, 2005. Phthalates and human health. Occup Environ Med, 62:806-818.
10	Swan SH, 2008. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res, 108:177-184
11	Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, Nelson H, Bhat HK, Perera FP, Silva MJ, Hauser R, 2008. Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples. Environ Health Perspect, 116:467-473.
12	Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, Mao CS, Redmon JB, Ternand CL, Sullivan S, Teague JL, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect, 113:1056-1061.
13	Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, Wetmur J, Calafat AM, 2008. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect, 116:1092-1097.
14	Moore KL, Persaud TVN, Shiota K, 2000. Color atlas of clinical embryology. Philadelphia, PA: W.B. Saunders.
15	Strauss JF, III., Martinez F., Kiriakidou M., 1996. Placental steroid hormone synthesis: unique features and unanswered questions. Biol Reprod, 54:303-311.
16	Challis JR, Bloomfield FH, Bocking AD, Casciani V, Chisaka H, Connor K, Dong X, Gluckman P, Harding JE, Johnstone J, Li W, Lye S, Okamura K, Premyslova M, 2005. Fetal signals and parturition. J Obstet Gynaecol Res, 31:492-499.
17	Myllynen P, Pasanen M, Pelkonen O, 2005. Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta, 26:361-371.
18	Benirschke K, Kaufmann P, Baergen RN, 2005. Pathology of the human placenta. 5th edition. New York: Springer.
19	Lucier GW, Nelson KG, Everson R.B., Wong T.K., Philpot R.M., Tiernan T., Taylor M., Sunahara G.I., 1987. Placental markers of human exposure to polychlorinated biphenyls and polychlorinated dibenzofurans. Environ Health Perspect, 76:79-87.
20	Kantola M, Purkunen R, Kroger P, Tooming A, Juravskaja J, Pasanen M, Saarikoski S, Vartiainen T, 2000. Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg. Environ Res, 83:54-66.
21	Lopez-Espinosa MJ, Granada A, Carreno J, Salvatierra M, Olea-Serrano F, Olea N, 2007. Organochlorine pesticides in placentas from Southern Spain and some related factors. Placenta, 28:631-638.
22	Ghidini A, Salafia CM, 2005. Histologic placental lesions in women with recurrent preterm delivery. Acta Obstet Gynecol Scand, 84:547-550.
23	Salafia CM, Maas E, Thorp JM, Eucker B, Pezzullo JC, Savitz DA, 2005. Measures of placental growth in relation to birth weight and gestational age. Am J Epidemiol, 162:991-998.
24	Salafia CM, Pezzullo JC, Charles AK, Ernst LM, Maas EM, Gross B, Pijnenborg R, 2005. Morphometry of the basal plate superficial uteroplacental vasculature in normal midtrimester and at term. Pediatr Dev Pathol, 8:639-646.
25	Ananth CV, Oyelese Y, Prasad V, Getahun D, Smulian JC, 2006. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol, 128:15-21.
26	Getahun D, Ananth CV, Peltier MR, Smulian JC, Vintzileos AM, 2006. Acute and chronic respiratory diseases in pregnancy: associations with placental abruption. Am J Obstet Gynecol, 195:1180-1184.
27	Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA, 2004. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 350:672-683.
28	Huuskonen P, Storvik M, Reinisalo M, Honkakoski P, Rysa J, Hakkola J, Pasanen M, 2008. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin Pharmacol Ther, 83:542-550.
29	Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA, 2008. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol, 199:e561-511.
30	Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S, Post M, Caniggia I, 2005. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab, 90:4299-4308.
31	Sood R, Zehnder JL, Druzin ML, Brown PO, 2006. Gene expression patterns in human placenta. Proc Natl Acad Sci USA, 103:5478-5483.
32	Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, Mc-Donagh S, Pereira L, Sali A, Fisher SJ, 2007. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology, 148:1059-1079.
33	Hakkola J, Pasanen M, Hukkanen J, Pelkonen O, Maenpaa J, Edwards RJ, Boobis AR, Raunio H, 1996. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol, 51:403-411.
34	Pasanen M, 1999. The expression and regulation of drug metabolism in human placenta. Adv Drug Deliv Rev, 38:81-97.
35	Schaiff WT, Barak Y, Sadovsky Y, 2006. The pleiotropic function of PPARgamma in the placenta. Mol Cell Endocrinol, 249:10-15.
36	Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM, 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell, 4:585-595.
37	Corton JC, Bocos C, Moreno ES, Merritt A, Cattley RC, Gustafsson JA, 1997. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. Biochimie, 79:151-162.
38	Davis BJ, Maronpot RR, Heindel JJ, 1994. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol, 128:216-223.
39	Davis BJ, Weaver R, Gaines LJ, Heindel JJ, 1994. Mono-(2-ethylhexyl) phthalate suppresses estradiol production independent of FSH-cAMP stimulation in rat granulosa cells. Toxicol Appl Pharmacol, 128:224-228.
40	Lovekamp-Swan T, Jetten AM, Davis BJ, 2003.Dual activation of PPARalpha and PPARgamma by mono-(2- , 201:133-141.
41	Maloney EK, Waxman DJ, 1999. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol, 161:209-218.
42	Xu Y, Agrawal S, Cook TJ, Knipp GT, 2008. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Placenta, 29:962-969.
43	Sullivan MH, 2004. Endocrine cell lines from the placenta. Mol Cell Endocrinol, 228:103-119.
44	Rodie VA, Young A, Jordan F, Sattar N, Greer IA, Freeman DJ, 2005. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig, 12:320-329.
45	Pidoux G, Gerbaud P, Laurendeau I, Guibourdenche J, Bertin G, Vidaud M, Evain-Brion D, Frendo JL, 2004. Large variability of trophoblast gene expression within and between human normal term placentae. Placenta, 25:469.
46	Wyatt SM, Kraus FT, Roh CR, Elchalal U, Nelson DM, Sadovsky Y, 2005. The correlation between sampling site and gene expression in the term human placenta. Placenta, 26:372-379.
47	Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y, 2005. Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta, 26:319-328.
48	Huggett J, Dheda K, Bustin S, Zumla A, 2005. Real-time RT-PCR normalisation; strategies and considerations. Genes Immun, 6:279-284.
49	Sehringer B, Zahradnik HP, Deppert WR, Simon M, Noethling C, Schaefer WR, 2005. Evaluation of different strategies for real-time RT-PCR expression analysis of corticotropin-releasing hormone and related proteins in human gestational tissues. Anal Bioanal Chem, 383:768-775.
50	Rozen S, Skaletsky HJ, 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology. Edited by: Krawetz S, Misener S. Totowa, NJ: Humana Press: 365-386.
51	Miyoshi Y, Ando A, Shiba E, Taguchi T, Tamaki Y, Noguchi S, 2001. Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer, 94:685-689.

First page Previous page